BFRIW Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 geg. 2024 @ 23:00):

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States...

Stats
Šios dienos apimtis	120.00
Vidutinė apimtis	0.00
Rinkos kapitalizacija	5.25M
EPS	$-0.00464 ( 2023-09-29 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0500
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-07-03	Lanckriet Heikki	Buy	0
2023-05-18	Monaco Erica L.	Buy	76 336	Common Stock
2023-05-18	Monaco Erica L.	Sell	76 336	Restricted Stock Units
2023-05-18	Luebbert Hermann	Buy	95 420	Common Stock
2023-05-18	Luebbert Hermann	Sell	95 420	Restricted Stock Units

INSIDER POWER
15.96
Last 5 transactions
Buy: 271 756 \| Sell: 171 756

Biofrontera Inc. Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Biofrontera Inc. Finansinės ataskaitos

Annual	2023
Pajamos:	$34.07M
Bruto pelnas:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2023
Pajamos:	$34.07M
Bruto pelnas:	$15.56M (45.68 %)
EPS:	$-13.02

FY	2022
Pajamos:	$28.67M
Bruto pelnas:	$13.49M (47.04 %)
EPS:	$-0.610

FY	2021
Pajamos:	$24.10M
Bruto pelnas:	$11.36M (47.13 %)
EPS:	$0

Financial Reports:

No articles found.

Biofrontera Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Biofrontera Inc.

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.